查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571635

注射给药装置市场规模、份额和趋势分析报告：按产品、治疗应用、最终用途、地区和细分市场预测，2024-2030 年

Injectable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Therapeutic Use, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

注射给药装置市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球注射给药器材市场规模预计将达到8,232.9亿美元。

预计2024年至2030年该市场将以8.7%的复合年增长率成长。糖尿病和癌症等慢性疾病的增加增加了对注射给药的需求。与其他传统的药物传递形式不同，注射剂绕过首过代谢，从而最大限度地提高药物的生物有效性。随着技术的进步，製造和销售的设备都是量身定制的，以满足患者的特定需求。

自行注射装置的出现使得无需医疗协助即可自我注射药物成为可能。生技药品市场正在发生许多以技术为导向的开拓，进一步提高了这些注射装置在具有挑战性的疾病领域的适用性。自动注射器让糖尿病患者可以使用自动注射器、笔和无针注射器来管理胰岛素水平。

该市场的主要限制因素是针头相关的伤害和感染疾病、监管报销的模糊性、注射药物的无菌性以及对其他毒性较小且更易于管理的药物输送系统的偏好。儘管有这些市场限制因素，注射给药产品的市场潜力仍然巨大，大多数主要参与者选择注射给药而不是其他给药形式。注射给药产业依产品类型分为两个子类型：自行注射装置和传统注射装置。此外，根据治疗应用，注射给药产业分为自体免疫疾病、荷尔蒙疾病、肿瘤等。

根据最终用户应用，注射给药产业分为其他行业，包括医院、家庭护理机构、研究设施、诊断和临床实验室。

注射给药装置市场报告亮点：

  • 预计肿瘤学在预测期内的复合年增长率将达到 9.3%。这是由于全球癌症发生率不断上升以及标靶治疗的进步。
  • 2023年市场占有率为53.2%，以医院为主。医院越来越多地采用先进的注射设备，因为它们能够提供快速的治疗效果，这在急诊医学和危机情况下至关重要。
  • 2023年北美给药装置市场占40.5%份额。北美有大量患有糖尿病、癌症和自体免疫疾病等慢性病的人口。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章註射给药装置市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 注射给药装置市场分析工具
    • 波特的分析
    • PESTEL分析

第四章註射给药装置市场：产品估算与趋势分析

  • 细分仪表板
  • 注射给药装置市场：2023 年及 2030 年产品变化分析
  • 装置
  • 配方

第五章註射给药装置市场：治疗应用的估计与趋势分析

  • 细分仪表板
  • 注射给药装置市场：2023 年和 2030 年治疗应用变化分析
  • 自体免疫疾病
  • 荷尔蒙失调
  • 肿瘤学
  • 其他的

第六章註射给药装置市场：最终用途估计与趋势分析

  • 细分仪表板
  • 注射给药装置市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 居家照护环境
  • 其他的

第七章註射给药装置市场：区域估计与趋势分析

  • 2023 年及 2030 年註射给药装置市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Baxter
    • Schott AG
    • BD
    • Eli Lilly and Company
    • Terumo Corporation
    • Elcam Medical
    • Unilife Corporation
    • Ypsomed AG
    • Gerresheimer AG
    • Sanofi
简介目录
Product Code: 978-1-68048-GVR-8

Injectable Drug Delivery Devices Market Growth & Trends:

The global injectable drug delivery devices market size is anticipated to reach USD 823.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.7% from 2024 to 2030. The increase in the number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first-pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.

With the advent of self-injection devices, injectable drugs can be self-administered without the need for medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.

The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with the majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.

The injectable drug delivery industry by end-user application is categorized into hospitals, home care settings, and others including research establishments, diagnostics, and clinical laboratories.

Injectable Drug Delivery Devices Market Report Highlights:

  • Oncology is anticipated to witness the fastest CAGR of 9.3% over the forecast period. This is due to the growing incidence of cancer globally and the evolution of targeted therapies.
  • Hospitals dominated the market with 53.2% share in 2023. Hospitals are increasingly adopting advanced injectable devices due to their ability to provide rapid therapeutic effects, which is crucial in emergency care and critical situations.
  • North America injectable drug delivery devices market dominated with 40.5% market share in 2023. North America has a significant population with chronic diseases such as diabetes, cancer, and autoimmune disorders.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Injectable Drug Delivery Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Injectable Drug Delivery Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Injectable Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Injectable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Devices
    • 4.3.1. Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Self-injection Devices
      • 4.3.2.1. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Conventional Devices
      • 4.3.3.1. Conventional Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Formulations
    • 4.4.1. Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Conventional Drug Delivery
      • 4.4.2.1. Conventional Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Novel Drug Delivery
      • 4.4.3.1. Novel Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Injectable Drug Delivery Devices Market: Therapeutic Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Autoimmune Disorders
    • 5.3.1. Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Hormonal Disorders
    • 5.4.1. Hormonal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Injectable Drug Delivery Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Injectable Drug Delivery Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Homecare Settings
    • 6.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Injectable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Baxter
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Schott AG
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. BD
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Eli Lilly and Company
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Terumo Corporation
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Elcam Medical
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Unilife Corporation
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Ypsomed AG
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Gerresheimer AG
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Sanofi
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives